• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Subtype-Specific Clinical Presentation, Medical Treatment and Family Impact of Influenza in Children One to Five Years of Age Treated in Outpatient Pr

tetano

Editor, Senior Moderator
Pediatr Infect Dis J. 2018 Feb 5. doi: 10.1097/INF.0000000000001935. [Epub ahead of print]
[h=1]Subtype-Specific Clinical Presentation, Medical Treatment and Family Impact of Influenza in Children One to Five Years of Age Treated in Outpatient Practices in Germany During Three Post-Pandemic Years, 2013-2015.[/h] Streng A, Prifert C[SUP]1[/SUP], Weissbrich B[SUP]1[/SUP], Sauerbrei A[SUP]2[/SUP], Schmidt-Ott R[SUP]3[/SUP], Liese JG[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Limited data on the influenza burden in pediatric outpatients are available, especially regarding direct comparison of the co-circulating (sub)types A(H1N1)pdm09, A(H3N2) and B.
[h=4]METHODS:[/h] Children 1-5 years of age, unvaccinated against influenza and presenting with febrile acute respiratory infections (ARI), were enrolled in 33 paediatric practices in Germany from 2013-2015 (January-May). Influenza was confirmed by multiplex PCR from pharyngeal swabs and (sub)typed.
[h=4]RESULTS:[/h] In 805 children with ARI, influenza was the most frequently detected respiratory virus (n=305; 37.9%). Of 217 influenza patients included, 122 (56.2%) were infected with A(H3N2), 56 (25.8%) with A(H1N1)pdm09, and 39 (18.0%) with B. Median age was 3.7 years (IQR 2.1-4.8); 11% had underlying conditions. Median fever duration was 4 days (IQR 3-5), and the disease duration was 9 days (IQR 7-12). Most frequent diagnoses were pharyngitis (26%), bronchitis (18%) and acute otitis media (AOM; 10%). Children received mainly antipyretics (86%) and adrenergic nasal drops/spray (53%); 9% received antibiotics and 3% oseltamivir. Thirty-six percent required at least one additional practice visit; 1% were hospitalized. Median absences from childcare were 5 days (IQR 3-7); parents lost 4 workdays (IQR 2-6). Symptoms, severity and impact on the family were largely unrelated to (sub)type. However, patients with A(H1N1)pdm09 had fewer underlying conditions (p=0.017), whereas patients with B more often had pharyngitis (p=0.022), AOM (p=0.012) and stenosing laryngotracheitis (p=0.007).
[h=4]CONCLUSIONS:[/h] Influenza was the most frequently detected viral pathogen in outpatient children with febrile, mostly uncomplicated ARI. In this setting, clinical manifestations and severity were similar across the (sub)types prevalent during the post-pandemic seasons.


PMID: 29406467 DOI: 10.1097/INF.0000000000001935
 
Back
Top Bottom